Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

NCT07357675 is registered in ClinicalTrials.gov with EBI Anti Sepsis BV as lead sponsor.

NCT NCT07357675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07357675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
Lead sponsor
EBI Anti Sepsis BV
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
July 1, 2027
Enrollment
300 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass graft surgery(cabg), coronary artery disease (cad)